
Does it excite you to apply machine learning across genomics, chemistry and imaging to shape how new medicines are discovered? And do you have experience evaluating, fine-tuning and deploying models that scientists actually use? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
As Director, Applied AI/ML and Statistics, Research, you will be Zealand Pharma’s expert in applying machine learning and statistical methods across biological, chemical and imaging data. You will decide which models and statistical methods are fit for which questions, adapt them to our data, and make them reliable and reusable across Research. You will lead translational data science projects that connect patient-derived multi-modal data with research and translational questions. You will also contribute to scientific and technology projects across our obesity and metabolic health pipeline.
We offer exciting responsibilities:
You are a hands-on machine learning scientist with breadth across data types and the judgment to know when a model is good enough for a decision. You move easily between a benchmark, a biology question and an engineering conversation. You explain complex results simply to scientists and senior leaders, and you push back when the evidence does not support the claim. You thrive in a growing team where you can shape how models are chosen, shared and used across Research.
Research AI and Computational Sciences is part of Discovery Research. The team brings data science, AI and computational methods into Zealand Pharma’s research, from target discovery to candidate nomination. It works across our research sites in Copenhagen, Denmark and Cambridge, Massachusetts. It collaborates closely with chemistry, biology, modelling and simulation, clinical development, and Digital, Data & Technology. The position reports to the VP, Head of Research AI and Computational Sciences.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold.
Interested in bonding with us? The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com

At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.
Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.
We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.